What’s Behind the Drop, and Are Other Tobacco Stocks Plummeting Today?

Quick Read

• UVV cratered 6%, breaking below its 52-week low after Q1 EPS missed by $0.45 and Tobacco Operations operating income collapsed 90%.

• While MO and PM slipped modestly on strong recent earnings, TPB surged 16% after Modern Oral pouch revenue jumped 149%.

• UVV’s 56-year dividend streak yields 6%, anchoring the bull case as management expects tobacco shipments to rebound in H2 FY27.

• Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Universal didn’t make the cut. Grab the names FREE today.

Shares of Universal (NYSE:UVV) are trading at $47.75, down 6.08% in the current session and off 3.51% over the past week. The slide follows a badly missed fiscal Q1 earnings report and pushes the leaf-tobacco merchant below its 52-week low of $47.66, breaking a support level that had held for months.

Earnings Miss Sparks a Fresh Leg Lower

Universal reported first-quarter fiscal 2027 results after the close on August 5, 2026, and the numbers were ugly. Adjusted EPS came in at -$0.20, missing the $0.25 consensus. Revenue of $523.78 million came in short of the $587.00 million estimate, a decline of 11.79% year over year.

The damage was concentrated in the core Tobacco Operations segment, where revenue fell 13% year over year to $437.13 million and operating income collapsed 90% to $3.47 million. Tobacco volumes were down 9% and prices down 6%, reflecting oversupply in flue-cured and burley markets. The Ingredients segment fared no better, with revenue of $86.65 million and a segment operating loss driven by weak CPG demand and elevated fixed costs at the expanded Lancaster facility.

Gross margin compressed 330 basis points to 15.9%, and operating income fell 93.23% to $2.30 million. CEO Preston Wigner acknowledged the environment, saying “Purchasing activity was slower as we and our customers evaluated green tobacco price trends amid oversupply conditions in flue-cured and burley markets.” This is the fourth consecutive quarterly disappointment, following a -142.59% EPS miss in Q4 FY26 that included a $41.06 million goodwill impairment.

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Universal didn’t make the cut. Grab the names FREE today.

The Drop Is a Universal-Specific Story

Peer action confirms this is a Universal-specific problem. The table below shows today’s move alongside the past week for the group.

Altria and Philip Morris are trading only modestly lower, and both reported clean beats in their most recent quarters, with Philip Morris raising its FY26 EPS guide to $8.26 to $8.41 on IQOS and ZYN strength. Turning Point Brands is the outlier in the other direction, up 16.42% on the week after its Q2 2026 earnings report on August 4 showed Modern Oral pouch revenue up 149%. The S&P 500 rose 3.51% over the same week, underscoring that UVV’s slide is a single-name story tied to leaf-tobacco oversupply and Universal’s ingredients drag.

What to Watch Next

The bull case still rests on the dividend and shipment timing. Universal declared its next $0.83 quarterly payout with a November 2, 2026 payment date, extending the streak to 56 consecutive years and pushing the yield to 6.43%. Management expects tobacco shipments to weight to the second half of FY27.

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Universal didn’t make the cut. Grab the names FREE today.

Contact [email protected] for any questions or corrections.